Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.11 $1.92 Thursday, 9th May 2024 OCGN stock ended at $1.67. This is 2.91% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 6.19% from a day low at $1.62 to a day high of $1.72.
90 days $0.525 $2.10
52 weeks $0.345 $2.10

Historical Ocugen Inc prices

Date Open High Low Close Volume
Apr 04, 2024 $1.55 $1.67 $1.51 $1.51 8 101 321
Apr 03, 2024 $1.37 $1.60 $1.36 $1.51 9 938 663
Apr 02, 2024 $1.44 $1.45 $1.34 $1.38 9 464 758
Apr 01, 2024 $1.61 $1.61 $1.43 $1.54 8 782 120
Mar 28, 2024 $1.75 $1.76 $1.57 $1.64 9 033 335
Mar 27, 2024 $1.73 $1.85 $1.62 $1.78 10 453 798
Mar 26, 2024 $1.83 $2.00 $1.52 $1.73 27 360 951
Mar 25, 2024 $1.87 $2.10 $1.72 $1.83 43 460 018
Mar 22, 2024 $1.45 $1.71 $1.41 $1.64 31 628 225
Mar 21, 2024 $1.32 $1.60 $1.30 $1.34 29 341 524
Mar 20, 2024 $1.11 $1.25 $1.10 $1.24 8 410 308
Mar 19, 2024 $1.05 $1.10 $1.03 $1.10 3 277 258
Mar 18, 2024 $1.09 $1.22 $1.01 $1.03 10 637 760
Mar 15, 2024 $1.05 $1.09 $1.02 $1.08 3 501 023
Mar 14, 2024 $1.06 $1.09 $1.01 $1.02 3 117 915
Mar 13, 2024 $1.00 $1.08 $0.99 $1.04 5 449 932
Mar 12, 2024 $0.96 $1.01 $0.96 $0.98 3 372 060
Mar 11, 2024 $1.00 $1.02 $0.93 $0.94 3 644 459
Mar 08, 2024 $1.04 $1.09 $0.98 $0.99 6 511 377
Mar 07, 2024 $0.89 $1.03 $0.87 $1.01 7 646 214
Mar 06, 2024 $0.85 $0.88 $0.84 $0.87 2 061 845
Mar 05, 2024 $0.88 $0.89 $0.80 $0.86 4 531 973
Mar 04, 2024 $0.96 $0.98 $0.87 $0.88 5 124 714
Mar 01, 2024 $0.95 $0.98 $0.90 $0.96 3 454 001
Feb 29, 2024 $0.95 $0.98 $0.90 $0.94 4 571 820
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT